retatrutide phase 3 triumph Delivers 22.6% Weight Loss in TRIUMPH-2 and TRIUMPH-3 Trials | Kh Mahfuz Ullah posted on the topic Retatrutide's July 23 Phase 3

PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165

Staying well-hydrated is crucial for managing side effects and overall function

With hyperalgesia, stubbing your toe hurts worse than it should

Overall, preclinical studies have shown that GLP-1RA reduces alcohol consumption, reduces motivation to drink alcohol, and prevents alcohol relapse, potentially reducing alcohol-induced reward [91]

Statistical analysis All in vitro data were analyzed using students t-test, one-way ANOVA, or two-way ANOVA in GraphPad Prism v8 software (www.graphpad.com/)